Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;46(6):6629-6645.
doi: 10.1007/s11033-019-05058-1. Epub 2019 Sep 5.

Markers of pancreatic cancer stem cells and their clinical and therapeutic implications

Arkadiusz Gzil  1 , Izabela Zarębska  2 , Wiktor Bursiewicz  2 , Paulina Antosik  2 , Dariusz Grzanka  2 , Łukasz Szylberg  2   3
Affiliations
Review

Markers of pancreatic cancer stem cells and their clinical and therapeutic implications

Arkadiusz Gzil et al. Mol Biol Rep. 2019 Dec.

Abstract

Pancreatic cancer (PC) is the fourth most common cause of death among all cancers. Poor prognosis of PC may be caused by a prevalence of cancer stem cells (CSCs). CSCs are a population of cancer cells showing stem cell-like characteristics. CSCs have the ability to self-renew and may initiate tumorigenesis. PC CSCs express markers such as CD133, CD24, CD44, DCLK1, CXCR4, ESA, Oct4 and ABCB1. There is a wide complexity of interaction and relationships between CSC markers in PC. These markers are negative prognostic factors and are connected with tumor recurrence and clinical progression. Additionally, PC CSCs are resistant to treatment with gemcitabine. Thus, most current therapies for PC are ineffective. Numerous studies have shown, that targeting of these proteins may increase both disease-free and overall survival in PC.

Keywords: Cancer stem cells; Pancreatic cancer; Prognostic factors.

PubMed Disclaimer

References

    1. Siegel RL, Miller KD, Jemal A (2017) Cancer Statistics, 2017. CA Cancer L Clin 67:7–30. https://doi.org/10.3322/caac.21387 - DOI
    1. World Cancer Report (2014) World Health Organization 2014. Chapter 5.7. ISBN 978-92-832-0429-9
    1. De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13(2):97 - DOI
    1. Krejs GJ (2010) Pancreatic cancer: epidemiology and risk factors. Dig Dis 28:355–358. https://doi.org/10.1159/000319414 - DOI - PubMed
    1. Maisonneuve P, Lowenfels AB (2014) Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol 44(1):186–198 - DOI

MeSH terms

LinkOut - more resources